Medigus Ltd Sponsored

Medigus Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm focuses on medical-related devices and products on internet and other online-related technologies, and vehicle and wireless charging activities. It operates through the following segments: Corporate, E-Commerce, Online, and Others. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Tel Aviv, Israel.

Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm focuses on medical-related devices and products on internet and other online-related technologies, and vehicle and wireless charging activities. It operates through the following segments: Corporate, E-Commerce, Online, and Others. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Tel Aviv, Israel.

OMER, Israel, May  19, 2020  (GLOBE NEWSWIRE) --  Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced that it intends to offer and sell American Depositary Shares and pre-funded warrants in an underwritten public offering.  The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Medigus Announces Proposed Public Offering

OMER, Israel, May  19, 2020  (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced that ScoutCam Inc. (OTC: SCTC), the Company’s subsidiary, entered into and consummated a securities purchase agreement with M. Arkin (1999) Ltd. in connection with an investment of $2,000,000.

ScoutCam receives $2 million investment from Mori Arkin, a leading life science and pharmaceutical entrepreneur

OMER, Israel, May  06, 2020  (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced that following the signing of a binding letter of intent with Polyrizon Ltd., a private company engaged in developing biological gels for the purpose of protecting patients against biological threats, it has been informed by Polyrizion regarding the filing of the US patent application.

Polyrizon Filed a US Patent Application for Formulations and Methods for Preventing Viral Infections by COVID-19 Virus

OMER, Israel, May  01, 2020  (GLOBE NEWSWIRE) --  Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced that following the signing of a collaboration agreement with L-1 Systems Ltd. for the joint commercialization of various COVID-19 related products and solutions to governmental agencies and institutional healthcare organizations, the companies received its first commercial order for COVID-19 serological test kits.

Medigus and L1 Systems Received First Commercial Order for COVID-19 Testing Kits

OMER, Israel, April  24, 2020  (GLOBE NEWSWIRE) --  Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced the signing of a binding letter of intent with Polyrizon Ltd., private company engaged in developing biological gels for the purpose of protecting patients against biological threats.

Medigus Signed a Binding Letter of Intent with Polyrizon for an Investment in and Joint Commercialization of Biological Gels for Protecting Patients against COVID-19 and Other Biological Threats

OMER, Israel, March  06, 2020  (GLOBE NEWSWIRE) --  Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced that on March 3, 2020, ScoutCam Inc. (OTC: SCTC) consummated an investment agreement for a total of $948,400 with certain investors. This investment reflects a post-investment valuation of approximately $14,500,000. Following the closing of the investment, Medigus will hold approximately 56% in ScoutCam.

ScoutCam Inc. Closes Investment Round and Raises $948,400 at a Valuation of approximately $14.5 Million

OMER, Israel, Feb.  14, 2020  (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced the signing of a $4,000,000 non-binding MOU agreement with L-1 Systems Ltd. for the licensing and sale of know-how and goods relating to the Medigus Ultrasonic Surgical Endostapler (MUSE™) system in the Latin America region. In addition, Medigus shall receive an additional payment of US$500,000 in consideration for support services to be provided during the first year following the execution of the definitive agreement.

Medigus Signs a Non-binding MOU for the License and Sale of the MUSE™ System in the Latin America Region for $4.5 Million

Intellisense Issues 60% of its Share Capital to Medigus and ScoutCam Becomes Wholly-Owned Subsidiary of Intellisense

Medigus and Intellisense Close Merger

This is the second installment out of a total amount of $3 million

Medigus Received Payment of $1.2M as Part of the Licensing and Sale Agreement for MUSE™ in Greater China

This investment represents a $10 million pre-money valuation for Scoutcam Ltd.

Intellisense Solutions Inc. Secures $3.5 Million Investment Ahead of Medigus Ltd.

OMER, Israel, Sept.  17, 2019  (GLOBE NEWSWIRE) --  Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced the signing of a securities exchange agreement with Intellisense Solutions Inc., a Nevada corporation whose shares of common stock are quoted on the OTC “Pink Sheets”. The transaction will result in Medigus’s wholly-owned subsidiary, ScoutCam Ltd., becoming a wholly-owned subsidiary of Intellisense, and in exchange Medigus will receive 60% of the issued and outstanding share capital of Intellisense.

Medigus and Intellisense Solutions Agree to Securities Exchange Effecting a Merger of ScoutCam

Medigus Ltd. shares are up 57% after the company announced along with A.M. Surgical, Inc., the two companies received an order worth $650,000 for 1,400 units for its integrated visualization device. It's the first "substantial commercial" order for the device.

News for Medigus Ltd Sponsored Stock (MDGS)